Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mônica Santos Schneider"'
Autor:
Grasiele S.V. Tavares, Mônica Santos Schneider, Ricardo Andrez Machado-de-Ávila, Thaís T.O. Santos, Rodrigo Maia de Pádua, João Paulo Viana Leite, Daniela P. Lage, Miguel A. Chávez-Fumagalli, Eduardo A.F. Coelho, Débora V.C. Mendonça
Publikováno v:
LOCUS Repositório Institucional da UFV
Universidade Federal de Viçosa (UFV)
instacron:UFV
Evidence-Based Complementary and Alternative Medicine, Vol 2018 (2018)
Universidade Federal de Viçosa (UFV)
instacron:UFV
Evidence-Based Complementary and Alternative Medicine, Vol 2018 (2018)
Background. The development of new therapeutic strategies to treat patients for leishmaniasis has become a priority. The antileishmanial activity of the strychnobiflavone flavonoid was recently demonstrated against Leishmania amazonensis and Leishman
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad1c417afaa3af4ff20c6cd48b3f47cd
http://www.locus.ufv.br/handle/123456789/24394
http://www.locus.ufv.br/handle/123456789/24394
Autor:
Manuel Soto, Mariana C. Duarte, Wiliam César Bento Régis, Eduardo A.F. Coelho, Nathália Cristina de Jesus Pereira, Jamil S. Oliveira, Carlos Alberto Pereira Tavares, Vívian T. Martins, Lourena E. Costa, Miguel A. Chávez-Fumagalli, Alanna Gomes da Silva, Sandra de Aguiar Soares, Maria Norma Melo, Paula S. Lage, Mônica Santos Schneider, José R.R. de Souza
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
© 2015 Elsevier Inc. The development of effective prophylactic strategies to prevent leishmaniasis has become a high priority. No less important than the choice of an antigen, the association of an appropriate adjuvant is necessary to achieve a succ
Autor:
Miguel Angel, Chávez-Fumagalli, Mônica Santos, Schneider, Daniela Pagliara, Lage, Grasiele de Sousa Vieira, Tavares, Débora Vasconcelos Costa, Mendonça, Thaís Teodoro de Oliveira, Santos, Rodrigo Maia, Pádua, Ricardo Andrez, Machado-de-Ávila, João Paulo Viana, Leite, Eduardo Antonio Ferraz, Coelho
Publikováno v:
Evidence-based Complementary and Alternative Medicine : eCAM
Background The development of new therapeutic strategies to treat patients for leishmaniasis has become a priority. The antileishmanial activity of the strychnobiflavone flavonoid was recently demonstrated against Leishmania amazonensis and Leishmani
Autor:
Eduardo A.F. Coelho, Mônica Santos Schneider, Daniela P. Lage, Ricardo Andrez Machado-de-Ávila, Miguel A. Chávez-Fumagalli
Publikováno v:
Experimental parasitology. 176
Leishmaniasis is a parasitic disease caused by the protozoan of the Leishmania genus. While no human vaccine is available, drugs such as pentavalent antimonials, pentamidine and amphotericin B are used for treat the patients. However, the high toxici
Autor:
Beatriz C.S. Salles, Vívian T. Martins, Lourena E. Costa, Marcelo P Oliveira, Daniel Dias, Ricardo Andrez Machado-de-Ávila, Antônio Lúcio Teixeira, Patrícia A.F. Ribeiro, Daniela P. Lage, Mônica Santos Schneider, Miguel A. Chávez-Fumagalli, Thaís T.O. Santos, Eduardo A.F. Coelho, Fernanda F. Ramos
Publikováno v:
International Journal of Molecular Sciences; Volume 19; Issue 1; Pages: 129
International Journal of Molecular Sciences
International Journal of Molecular Sciences
In a proteomics approach conducted with Leishmania amazonensis, parasite proteins showed either an increase or a decrease in their expression content during extensive in vitro cultivation, and were related to the survival and the infectivity of the p